Mycobacterium bovis is the causative agent of bovine tuberculosis (bTB), a chronic infectious disease that predominantly infects domestic cattle and various species of wildlife (e.g. deer and badgers). In the UK, cattle displaying bTB symptoms are systematically culled, with 21,298 culling occurring between April 2023 and March 2024 - a 5% increase from last year's 20,121 culls [1]. This costs the government £120 million a year, of which £50 million falls on farmers alone [1] .
But the impact of bTB extends beyond finances, having significant impacts on farmers and their family's mental wellbeing, not only from the culling of their herds but also from the mere threat of a positive bTB test result [1]. Additionally, while bTB is primarily expressed in cattle, humans in close contact with them are also susceptible to infection. In regions where subsistence farming is more prevalent, bTB transmission from livestock to their handlers results in approximately 140,000 human TB cases and 12,000 deaths per year [2][3]. It is therefore no exaggeration to say that, across the world, bTB represents a serious, global threat to livestock, rural economies and farmer's livelihoods and wellbeing [2][3].